Molecular docking revealed interaction of RES and AJM with catalytic site residues of studied AD targets (Aβ42, AChE, BuChE, BACE-1, and MAO-B) giving insight of the mechanism of inhibition of respective enzymes and peptide that correlate with in vitro studies. Here, BACE1 is linked to Alzheimer disease.